BILLS-110hr2900eh.pdf

2007 annual fiscal year 30 days later than 180 days 2012 later than 30 days fiscal year 2009 30-day fiscal year 2008 a fiscal year later than 1 year such fiscal year six months 180-day each fiscal year 2009 15 days fiscal year 2007 later than 120 days later than 90 days fiscal year 2012 fiscal years 12-month the next fiscal year October 1, 2007 annually later than one year later than 5 days later than 60 days October 1, 2012 each year one year 2 year 17 year 2003 the fiscal year fiscal year 2010 20 days 23 year 2 years five-year any fiscal year 2011 previous year 10 year each of the fiscal years 2008 through 2012 6 year 15 year 2008

the ‘‘Best Pharmaceuticals the ‘‘Act the ‘‘Pediatric Medical the ‘‘Pediatric Research the ‘‘Administra- 16 SESSION H. R. 2900 the ‘‘Food and Drug Ad-

502(4

United States the United States Pediatric the District of Columbia Treas- CONTENTS.—A 24 States Founda- the District of Columbia Circuit cludes the United States of America U.S.

appro- 11 appro- 16

Cosmetic 510(k FUNDING.—The APPROPRIATIONS.—To Indian

SEC the Federal Food, Drug U.S.C. the Food and Drug Administration Congress NIH Food and Drug Administration Drug Administration Foundation DTC the Public Health Service Act Federal Food and Drugs Board Senate Health and Human Services the Federal Register Labor Food, Drug the Federal Food the Pediatric Advisory Committee the House of Representatives GENERAL.—If the Food and Drug Administra- Federal Food, Drug Food the Best Pharmaceuticals for Children Act the Best Pharmaceuticals Office the Committee on Energy the Committee on Health, Education the National Institutes of Health State uct National Institutes of Health Drug the Committee on Health United Pediatric Advisory Committee the Commissioner of Food the Food and Drug Admin- Health Federal Register the Food and Drug the Pediatric Advisory House -Udall Foundation Healthcare Research and Quality Best Pharmaceuticals the Pediatric Research Equity Act

Reagan SIBLE.—If mary Subparagraph ting

postmarket pediatric user fee drugs fee amendments medical devices drugs sec clinical trial device medical device user drug devices sec clinical prescription